VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

H.R. 3689 · 110th Congress

Ovarian Cancer Biomarker Research Act of 2007

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 110th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

HBD BermanSponsor
97 cosponsors · 76 D, 21 R
DBR Burton ECD Cleaver RDD DeLauro JAR Ann Davis SFD Farr GGD Green RHR Hall MHD Honda DIR Issa SID Israel PKR King BLD Lee CMD McCarthy JMD McDermott MMD McNulty PMD Murphy GRR Radanovich BRD Rush ETD Tauscher FWR Wolf AWD Weiner DMD Matsui JND Nadler LSD Slaughter DDD DeGette RKD Kind JBD Barrow SCD Cohen DPD Price SBR Bachus RBD Boucher BSD Sutton TPR Platts JSD Salazar EMD Markey GMD Miller LCD Capps WCD Clay SLR LaTourette MRD Ross JBD Baca KED Ellison MFR Ferguson AGD Green ZLD Lofgren FLR LoBiondo EED Engel MMR McCaul SBD Berkley JCD Carson DDD Davis JHD Harman ETD Towns HWD Waxman BCD Cramer ECD Cummings SDD Davis BFD Filner BMD McCollum DPR Pryce TAD Allen JSD Sestak TMR McCotter MHD Hinchey LSD Sanchez JBR Boozman YCD Clarke RHD Hinojosa WJD Jefferson PKD Kennedy TBD Baldwin CGD Gonzalez CVD Van Hollen JYD Yarmuth MUD Udall RFR Frelinghuysen ACD Carson CMD Maloney BBD Baird JMD Marshall VSD Snyder JSD Spratt JTD Tierney SBD Bishop KGD Gillibrand RWR Wittman NVD Velázquez MBR Bachmann MMD Michaud TPR Poe RND Neal JAD Altmire MCD Capuano BFD Frank CSD Shea-Porter CFD Fattah RKR Kuhl

21 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

Ovarian Cancer Biomarker Research Act of 2007 - Amends the Public Health Service Act to require the Director of the National Cancer Institute to enter into cooperative agreements with, or make grants to, public or nonprofit entities to establish and operate centers to conduct research on biomarkers for use in risk stratification for, and the early detection…

What it does: CRS summary · Introduced in House · Sep 27, 2007

Ovarian Cancer Biomarker Research Act of 2007 - Amends the Public Health Service Act to require the Director of the National Cancer Institute to enter into cooperative agreements with, or make grants to, public or nonprofit entities to establish and operate centers to conduct research on biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer. Designates each center as an Ovarian Cancer Biomarker Center of Excellence.

Allows federal payments under such an agreement or grant to be used for research on: (1) the development and characterization of new biomarkers and the refinement of existing biomarkers; (2) the clinical and laboratory validation of such biomarkers; (3) the development and implementation of clinical and epidemiological research on the utilization of such biomarkers; and (4) the development and implementation of repositories for new tissue, urine, serum, and other biological specimens.

Requires the Director to: (1) make available for research banked serum and tissue specimens from clinical research regarding ovarian cancer that was funded by the Department of Health and Human Services (HHS); (2) establish an Ovarian Cancer Biomarker Clinical Trial Committee to assist the Director to design and implement national clinical trials to determine the utility of such biomarkers; and (3) establish a national data center to conduct statistical analyses of trial data.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Ovarian Cancer Biomarker Research Act of 2007

Latest action (Nov 8, 2007): Referred to the Subcommittee on Health.

Policy area: Health · Origin: House · Introduced: Sep 27, 2007

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.